"Sorafenib" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonHypoxia-induced DTL promotes the proliferation, metastasis, and sorafenib resistance of hepatocel...
Research progress of sorafenib drug delivery system in the treatment of hepatocellular carcinoma:...
Research progress of sorafenib drug delivery system in the treatment of hepatocellular carcinoma: An update ScienceDirect.com
Sorafenib Plus TACE Prolongs Survival in Recurrent HCC - Medscape
Sorafenib Plus TACE Prolongs Survival in Recurrent HCC Medscape
FDA Accepts NDA Resubmission for First-Line Rivoceranib/Camrelizumab Combo in Unresectable HCC - ...
FDA Accepts NDA Resubmission for First-Line Rivoceranib/Camrelizumab Combo in Unresectable HCC OncLive
Mitochondrial GCN5L1 acts as a novel regulator for iron homeostasis to promote sorafenib sensitiv...
Mitochondrial GCN5L1 acts as a novel regulator for iron homeostasis to promote sorafenib sensitivity in hepatocellular carcinoma Journal of Translational Medicine
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312...
The Role of Bcl‐2 Family Proteins and Sorafenib Resistance in Hepatocellular Carcinoma - Wiley On...
The Role of Bcl‐2 Family Proteins and Sorafenib Resistance in Hepatocellular Carcinoma Wiley Online Library
Sorafenib-mediated cleavage of p62 initiates cellular senescence as a mechanism to evade its anti...
Frontline Camrelizumab/Rivoceranib Prolongs OS vs Sorafenib in Unresectable HCC - OncLive
Frontline Camrelizumab/Rivoceranib Prolongs OS vs Sorafenib in Unresectable HCC OncLive
Remodeling of sorafenib as an orally bioavailable ferroptosis inducer for Lung Cancer by chemical...
Remodeling of sorafenib as an orally bioavailable ferroptosis inducer for Lung Cancer by chemical modification of adenine-binding motif ScienceDirect.com
Sorafenib inhibits ossification of the posterior longitudinal ligament by blocking LOXL2-mediated...
Inhibition of PTPRE suppresses tumor progression and improves sorafenib response in hepatocellula...
Inhibition of PTPRE suppresses tumor progression and improves sorafenib response in hepatocellular carcinoma ScienceDirect.com
Phosphorylated FOXQ1, a novel substrate of JNK1, inhibits sorafenib-induced ferroptosis by activa...
Deubiquitylase OTUD3 regulates integrated stress response to suppress progression and sorafenib r...
Deubiquitylase OTUD3 regulates integrated stress response to suppress progression and sorafenib resistance of liver cancer ScienceDirect.com
Autophagy modulation attenuates sorafenib resistance in HCC induced in rats - Nature.com
Autophagy modulation attenuates sorafenib resistance in HCC induced in rats Nature.com
LARP4B promotes hepatocellular carcinoma progression and impairs sorafenib efficacy by activating...
Impact of glucose metabolism on PD-L1 expression in sorafenib-resistant hepatocellular carcinoma ...
MCL1 inhibition: a promising approach to augment the efficacy of sorafenib in NSCLC through ferro...
Novel STAT3 oligonucleotide compounds suppress tumor growth and overcome the acquired resistance ...
TFCP2L1 drives stemness and enhances their resistance to Sorafenib treatment by modulating the NA...
Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center e...
Toripalimab Combo May Improve Survival Vs Sorafenib in Advanced HCC - Cancer Network
Toripalimab Combo May Improve Survival Vs Sorafenib in Advanced HCC Cancer Network
Enhanced anticancer activity of silver doped zinc oxide magnetic nanocarrier loaded with sorafeni...
Camrelizumab Plus Rivoceranib vs Sorafenib as First-Line Therapy for Unresectable Hepatocellular ...
Mechanism of sorafenib resistance associated with ferroptosis in HCC - Frontiers
Mechanism of sorafenib resistance associated with ferroptosis in HCC Frontiers
First-Line Camrelizumab Plus Rivoceranib Maintains Survival Benefit in Unresectable HCC - OncLive
First-Line Camrelizumab Plus Rivoceranib Maintains Survival Benefit in Unresectable HCC OncLive
From synergy to resistance: Navigating the complex relationship between sorafenib and ferroptosis...
From synergy to resistance: Navigating the complex relationship between sorafenib and ferroptosis in hepatocellular carcinoma ScienceDirect.com
Caffeic acid phenethyl ester derivative exerts remarkable anti-hepatocellular carcinoma effect, n...
Radiotherapy plus lenvatinib versus radiotherapy plus sorafenib for hepatocellular carcinoma with...
Selective therapeutic efficacy of tyrosine kinase inhibitor sorafenib on the restoration of methy...
Selective therapeutic efficacy of tyrosine kinase inhibitor sorafenib on the restoration of methylglyoxal-induced peritoneal fibrosis ScienceDirect.com
Ropivacaine synergizes with sorafenib to induce apoptosis of hepatocellular carcinoma cells via t...
Ropivacaine synergizes with sorafenib to induce apoptosis of hepatocellular carcinoma cells via the IL-6/STAT3 pathway Wiley Online Library
RNA helicase DDX5 modulates sorafenib sensitivity in hepatocellular carcinoma via the Wnt/β-caten...
Rachna T. Shroff, MD, MS, FASCO, on Advanced Hepatocellular Carcinoma: Anlotinib Plus Penpulimab ...
Rachna T. Shroff, MD, MS, FASCO, on Advanced Hepatocellular Carcinoma: Anlotinib Plus Penpulimab vs Sorafenib The ASCO Post
Development of fucoidan/polyethyleneimine based sorafenib-loaded self-assembled nanoparticles wit...
SOD1 inhibition enhances sorafenib efficacy in HBV-related hepatocellular carcinoma by modulating...
SOD1 inhibition enhances sorafenib efficacy in HBV-related hepatocellular carcinoma by modulating PI3K/Akt/mTOR pathway and ROS-mediated cell death Wiley Online Library
Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World U...
IL-22 signaling promotes sorafenib resistance in hepatocellular carcinoma via STAT3/CD155 signali...
MRI radiomics to monitor therapeutic outcome of sorafenib plus IHA transcatheter NK cell combinat...
MRI radiomics to monitor therapeutic outcome of sorafenib plus IHA transcatheter NK cell combination therapy in hepatocellular carcinoma Journal of Translational Medicine
Discovery points to new approach to treating liver cancer - Purdue University
Discovery points to new approach to treating liver cancer Purdue University
CheckMate-9DW: First-Line Nivolumab/Ipilimumab Prolongs Overall Survival, Yields High Objective R...
CheckMate-9DW: First-Line Nivolumab/Ipilimumab Prolongs Overall Survival, Yields High Objective Response Rate in Unresectable HCC ASCO Daily News
Co-Delivery of siNRF2 and Sorafenib by a “Click” Dual Functioned Hyperbranched Nanocarrier for Sy...
Co-Delivery of siNRF2 and Sorafenib by a “Click” Dual Functioned Hyperbranched Nanocarrier for Synergistically Inducing Ferroptosis in Hepatocellular Carcinoma Wiley Online Library
First-Line Nivolumab Plus Ipilimumab Could Become New Standard Care for HCC - Cancer Therapy Advisor
First-Line Nivolumab Plus Ipilimumab Could Become New Standard Care for HCC Cancer Therapy Advisor
Case report: Precision guided reactive cancer management: molecular complete response in heavily ...
Efficacy of lenvatinib versus sorafenib in the primary treatment of advanced hepatocellular carci...
Efficacy of lenvatinib versus sorafenib in the primary treatment of advanced hepatocellular carcinoma: A meta-analysis Wiley Online Library
Suppression of AGTR1 Induces Cellular Senescence in Hepatocellular Carcinoma Through Inactivating...
Long Noncoding RNA URB1-Antisense RNA 1 (AS1) Suppresses Sorafenib-Induced Ferroptosis in Hepatoc...
Long Noncoding RNA URB1-Antisense RNA 1 (AS1) Suppresses Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma by Driving Ferritin Phase Separation ACS Publications
METTL3 and METTL14-mediated N6-methyladenosine modification of SREBF2-AS1 facilitates hepatocellu...
Development of fucoidan/polyethyleneimine based sorafenib-loaded self-assembled nanoparticles wit...
Camrelizumab Plus Rivoceranib Improves Survival vs Standard First-Line Care for HCC - AJMC.com Ma...
Camrelizumab Plus Rivoceranib Improves Survival vs Standard First-Line Care for HCC AJMC.com Managed Markets Network
l‐Methionine potentiates anticancer activity of Sorafenib by epigenetically altering DUSP3/ERK pa...
l‐Methionine potentiates anticancer activity of Sorafenib by epigenetically altering DUSP3/ERK pathway in hepatocellular carcinoma Wiley Online Library
Mechanisms of sorafenib resistance in HCC. (IMAGE) - EurekAlert
Mechanisms of sorafenib resistance in HCC. (IMAGE) EurekAlert
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therape...
Sorafenib in Advanced Hepatocellular Carcinoma - nejm.org
Sorafenib for Advanced and Refractory Desmoid Tumors - nejm.org
Sorafenib for Advanced and Refractory Desmoid Tumors nejm.org
Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines | Cell Death & Di...
Astaxanthin Augmented the Anti‐Hepatocellular Carcinoma Efficacy of Sorafenib Through the Inhibit...
Nirogacestat Approval Offers Choice to Desmoid Tumor Population - Cancer Network
Nirogacestat Approval Offers Choice to Desmoid Tumor Population Cancer Network
Co-Delivery of siNRF2 and Sorafenib by a “Click” Dual Functioned Hyperbranched Nanocarrier for Sy...
Co-Delivery of siNRF2 and Sorafenib by a “Click” Dual Functioned Hyperbranched Nanocarrier for Synergistically Inducing Ferroptosis in Hepatocellular Carcinoma Wiley Online Library
Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors - Nature.com
Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors Nature.com
Oral sorafenib-loaded microemulsion for breast cancer: evidences from the in-vitro evaluations an...
Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cance...
Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FL...
Target immune components to circumvent sorafenib resistance in hepatocellular carcinoma - Science...
Target immune components to circumvent sorafenib resistance in hepatocellular carcinoma ScienceDirect.com
Efficacy and safety of lenvatinib versus sorafenib in first-line treatment of advanced hepatocell...
SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glut...
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in ...
Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma - Nature.com
Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma Nature.com
Sorafenib and nitazoxanide disrupt mitochondrial function and inhibit regrowth capacity in three-...
GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition o...
Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib res...
Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-u...
Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid ...
Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: pa...
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular ...
Combination therapy of tyrosine kinase inhibitor sorafenib with the HSP90 inhibitor onalespib as ...
UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeosta...
Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study - ...
Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study Nature.com
CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1 - Natu...
CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1 Nature.com
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312...
Abstract 17777: Sorafenib Aggravates Atherosclerotic Progression Involving With Vascular Smooth M...
Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma i...
Activation of c-Jun predicts a poor response to sorafenib in hepatocellular carcinoma: Preliminar...
Astaxanthin Augmented the Anti‐Hepatocellular Carcinoma Efficacy of Sorafenib Through the Inhibit...
Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis...
Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis ScienceDirect.com
miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR - N...
miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR Nature.com
Sorafenib suppresses extrahepatic metastasis de novo in hepatocellular carcinoma through inhibiti...
Sorafenib inhibits LPS-induced inflammation by regulating Lyn-MAPK-NF-kB/AP-1 pathway and TLR4 ex...
TRIM21 mediates the synergistic effect of Olaparib and Sorafenib by degrading BRCA1 through ubiqu...
ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma - Nature.com
ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma Nature.com
Tivozanib versus sorafenib in patients with advanced renal cell carcinoma (TIVO-3): a phase 3, mu...
BH3-only protein expression determines hepatocellular carcinoma response to sorafenib-based treat...
A Photoactivated Sorafenib-Ruthenium(II) Prodrug for Resistant Hepatocellular Carcinoma Therapy t...
A Photoactivated Sorafenib-Ruthenium(II) Prodrug for Resistant Hepatocellular Carcinoma Therapy through Ferroptosis and Purine Metabolism Disruption ACS Publications
PLEKHG5 is stabilized by HDAC2-related deacetylation and confers sorafenib resistance in hepatoce...
Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellu...
The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular...
Impact of genetic patterns on sorafenib efficacy in patients with FLT3-ITD acute myeloid leukemia...
The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular ca...
The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade f...
Data Show Sorafenib After Transplant Improves OS in FLT3-ITD AML, but Questions Persist - Oncolog...
Data Show Sorafenib After Transplant Improves OS in FLT3-ITD AML, but Questions Persist Oncology News Central
USP29-mediated HIF1α stabilization is associated with Sorafenib resistance of hepatocellular carc...